JOHN GLENN - 11 Dec 2025 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ John Glenn
Issuer symbol
IRMD
Transactions as of
11 Dec 2025
Transactions value $
-$1,528,871
Form type
4
Filing time
12 Dec 2025, 17:00:16 UTC
Previous filing
10 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GLENN JOHN CHIEF FINANCIAL OFFICER C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO /s/ John Glenn 12 Dec 2025 0001253497

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Sale -$1.41M -14.5K -64.7% $97.26 7.89K 11 Dec 2025 Direct F1
transaction IRMD Common Stock Sale -$52.2K -532 -6.74% $98.09 7.36K 11 Dec 2025 Direct
transaction IRMD Common Stock Options Exercise +1.81K +24.61% 9.17K 11 Dec 2025 Direct F2
transaction IRMD Common Stock Tax liability -$69.5K -714 -7.78% $97.38 8.46K 11 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -1.81K -33.33% $0.00 3.62K 11 Dec 2025 Common Stock 1.81K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $97.00 to $97.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Restricted stock units convert into common stock on a one-for-one basis.
F3 The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.